These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16370079)

  • 21. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal response to dehydroepiandrosterone administration in schizophrenia: findings from a randomized, double-blind, placebo-controlled, crossover study.
    Strous RD; Gibel A; Maayan R; Weizman A; Ritsner MS
    J Clin Psychopharmacol; 2008 Aug; 28(4):456-9. PubMed ID: 18626277
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia.
    Mössner R; Schuhmacher A; Kühn KU; Cvetanovska G; Rujescu D; Zill P; Quednow BB; Rietschel M; Wölwer W; Gaebel W; Wagner M; Maier W
    Pharmacogenet Genomics; 2009 Jan; 19(1):91-4. PubMed ID: 18849890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other.
    Fleischhacker WW; Widschwendter CG
    Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 27. [FDA phase II and phase III drug evaluation of antipsychotic agents].
    Yagi K
    Seishin Shinkeigaku Zasshi; 1990; 92(9):584-92. PubMed ID: 1980369
    [No Abstract]   [Full Text] [Related]  

  • 28. The CATIE study.
    Basil B; Mathews M; Adetunji B; Budur K
    Am J Psychiatry; 2006 Mar; 163(3):555; author reply 555-6. PubMed ID: 16513895
    [No Abstract]   [Full Text] [Related]  

  • 29. Ranking Antipsychotics for Efficacy and Safety in Schizophrenia.
    Correll CU; Kane JM
    JAMA Psychiatry; 2020 Mar; 77(3):225-226. PubMed ID: 31693073
    [No Abstract]   [Full Text] [Related]  

  • 30. Apomorphine in schizophrenia.
    Hollister LE; Davis KL; Berger PA
    Commun Psychopharmacol; 1980; 4(4):277-81. PubMed ID: 6115735
    [No Abstract]   [Full Text] [Related]  

  • 31. An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
    McEvoy JP
    CNS Spectr; 2006 Jul; 11(7 Suppl 7):4-8. PubMed ID: 16816794
    [No Abstract]   [Full Text] [Related]  

  • 32. The spurious advance of antipsychotic drug therapy.
    Tyrer P; Kendall T
    Lancet; 2009 Jan; 373(9657):4-5. PubMed ID: 19058841
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcomes similar with first- and second-generation antipsychotics.
    Seidlinger J; Provost GP
    Am J Health Syst Pharm; 2006 Nov; 63(22):2172, 2175. PubMed ID: 17090731
    [No Abstract]   [Full Text] [Related]  

  • 34. Newer antipsychotics in treatment-resistant schizophrenia.
    Marder SR
    Biol Psychiatry; 1999 Feb; 45(4):383-4. PubMed ID: 10071705
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutism, akinesis, and fever: a review.
    Martin RD
    Ariz Med; 1981 Apr; 38(4):268-70. PubMed ID: 6112976
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of antipsychotics on plasma lipids.
    Sramek JJ; Cutler NR; Shiovitz T
    J Clin Psychopharmacol; 2003 Dec; 23(6):679-80. PubMed ID: 14624207
    [No Abstract]   [Full Text] [Related]  

  • 37. Antipsychotic effect of gamma-type endorphins in schizophrenia.
    van Ree JM; de Wied D; Verhoeven WM; van Praag HM
    Lancet; 1980 Dec 20-27; 2(8208-8209):1363-4. PubMed ID: 6109172
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evidence of evidence-based medicine?].
    Helmchen H
    Nervenarzt; 2002 Jan; 73(1):1-2. PubMed ID: 11975058
    [No Abstract]   [Full Text] [Related]  

  • 39. Do antipsychotics cause hip fractures? Promise and pitfalls of big data.
    Davis JM; Ramsden CE
    J Clin Psychiatry; 2015 Sep; 76(9):e1155-6. PubMed ID: 26455690
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on the intermediate course of schizophrenia].
    Inoue S; Ogawa K; Hashizume H
    Seishin Shinkeigaku Zasshi; 2004; 106(11):1410-3. PubMed ID: 15835020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.